Literature DB >> 30642977

Cutting Edge: ICOS-Deficient Regulatory T Cells Display Normal Induction of Il10 but Readily Downregulate Expression of Foxp3.

Ashley E Landuyt1, Barbara J Klocke1, Tyler B Colvin1, Trenton R Schoeb2, Craig L Maynard3.   

Abstract

The ICOS pathway has been implicated in the development and functions of regulatory T (Treg) cells, including those producing IL-10. Treg cell-derived IL-10 is indispensable for the establishment and maintenance of intestinal immune homeostasis. We examined the possible involvement of the ICOS pathway in the accumulation of murine colonic Foxp3- and/or IL-10-expressing cells. We show that ICOS deficiency does not impair induction of IL-10 by intestinal CD4 T cells but, instead, triggers substantial reductions in gut-resident and peripherally derived Foxp3+ Treg cells. ICOS deficiency is associated with reduced demethylation of Foxp3 CNS2 and enhanced loss of Foxp3. This instability significantly limits the ability of ICOS-deficient Treg cells to reverse ongoing inflammation. Collectively, our results identify a novel role for ICOS costimulation in imprinting the functional stability of Foxp3 that is required for the retention of full Treg cell function in the periphery.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30642977      PMCID: PMC6363853          DOI: 10.4049/jimmunol.1801266

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Combination Treatment with Antigen-Specific Dual-Sized Microparticle System Plus Anti-CD3 Immunotherapy Fails to Synergize to Improve Late-Stage Type 1 Diabetes Prevention in Nonobese Diabetic Mice.

Authors:  J M Stewart; A L Posgai; J J Leon; M J Haller; B G Keselowsky
Journal:  ACS Biomater Sci Eng       Date:  2020-09-10

2.  ICOS ligand and IL-10 synergize to promote host-microbiota mutualism.

Authors:  Ashley E Landuyt; Barbara J Klocke; Lennard W Duck; Keri M Kemp; Rachel Q Muir; Melissa S Jennings; Samuel I Blum; Hubert M Tse; Goo Lee; Casey D Morrow; Charles O Elson; Craig L Maynard
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-30       Impact factor: 11.205

Review 3.  Role of CNSs Conserved Distal Cis-Regulatory Elements in CD4 + T Cell Development and Differentiation.

Authors:  Xunyi Long; Chen Luo; Zhengming Zhu
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

4.  Higher Frequency and Increased Expression of Molecules Associated with Suppression on T Regulatory Cells from Newborn Compared with Adult Nonhuman Primates.

Authors:  Beth C Holbrook; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2020-09-02       Impact factor: 5.422

5.  The impact of ICOS+ regulatory T cells and Helicobacter pylori infection on the prognosis of patients with gastric and colorectal cancer: potential prognostic benefit of pre-operative eradication therapy.

Authors:  Shinya Urakawa; Makoto Yamasaki; Tomoki Makino; Yukinori Kurokawa; Kei Yamamoto; Kumiko Goto; Miya Haruna; Michinari Hirata; Akiko Morimoto-Okazawa; Atsunari Kawashima; Kota Iwahori; Tsunekazu Mizushima; Eiichi Sato; Masaki Mori; Yuichiro Doki; Hisashi Wada
Journal:  Cancer Immunol Immunother       Date:  2020-08-16       Impact factor: 6.968

Review 6.  Immune dysregulation in patients with RAG deficiency and other forms of combined immune deficiency.

Authors:  Ottavia M Delmonte; Anna Villa; Luigi D Notarangelo
Journal:  Blood       Date:  2020-02-27       Impact factor: 22.113

7.  A tumor-specific mechanism of Treg enrichment mediated by the integrin αvβ8.

Authors:  Robert I Seed; Kenji Kobayashi; Saburo Ito; Naoki Takasaka; Anthony Cormier; Jillian M Jespersen; Jean Publicover; Suprita Trilok; Alexis J Combes; Nayvin W Chew; Jocelyne Chapman; Matthew F Krummel; Jianlong Lou; James Marks; Yifan Cheng; Jody L Baron; Stephen L Nishimura
Journal:  Sci Immunol       Date:  2021-03-26

8.  Effects of checkpoint kinase 1 inhibition by prexasertib on the tumor immune microenvironment of head and neck squamous cell carcinoma.

Authors:  Ritu Chaudhary; Robbert J C Slebos; Feifei Song; Keegan P McCleary-Sharpe; Jude Masannat; Aik Choon Tan; Xuefeng Wang; Nelusha Amaladas; Wenjuan Wu; Gerald E Hall; Jose R Conejo-Garcia; Juan C Hernandez-Prera; Christine H Chung
Journal:  Mol Carcinog       Date:  2020-12-30       Impact factor: 4.784

9.  Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation tolerance.

Authors:  Toshihito Hirai; Teresa L Ramos; Po-Yu Lin; Federico Simonetta; Leon L Su; Lora K Picton; Jeanette Baker; Jian-Xin Lin; Peng Li; Kinya Seo; Juliane K Lohmeyer; Sara Bolivar-Wagers; Melissa Mavers; Warren J Leonard; Bruce R Blazar; K Christopher Garcia; Robert S Negrin
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 19.456

10.  In situ conversion of defective Treg into SuperTreg cells to treat advanced IPEX-like disorders in mice.

Authors:  Yongqin Li; Yuxin Chen; Shaoshuai Mao; Ravinder Kaundal; Zhengyu Jing; Qin Chen; Xinxin Wang; Jing Xia; Dahai Liu; Jianlong Sun; Haopeng Wang; Tian Chi
Journal:  Nat Commun       Date:  2020-06-03       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.